CORPUS PHARMA
ActiveCORPUS PHARMA has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €66k and a net result of €-11k. Equity is growing by ~24.8% per year across the filed fiscal years. Its solvency ranks better than 88% of 17964 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0▼-5
Solvency100=
Growth52=
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity ample (current ratio 5.06 against 6.11 in 2024), and 18.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
81.3%
Return on assets
-13.6%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 d early
2024
35 d early
2023
58 d early
2022
61 d early
2021
74 d early
2020
60 d early
2019
49 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€66k▼ 14.4%
2024 · €78k
2018: €-19k
2019: €7k
2020: €33k
2021: €49k
2022: €67k
2023: €77k
2024: €78k
2018 → 2025
Total assets
€82k▼ 10.6%
2024 · €92k
2018: €66k
2019: €96k
2020: €49k
2021: €65k
2022: €86k
2023: €95k
2024: €92k
2018 → 2025
Net result
€-11k
2024 · €808
2018: €20k
2019: €27k
2020: €26k
2021: €16k
2022: €18k
2023: €10k
2024: €808
2018 → 2025
Working capital
€62k▼ 11.4%
2024 · €70k
2018: €-19k
2019: €7k
2020: €31k
2021: €48k
2022: €67k
2023: €77k
2024: €70k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€49k-€67k▲ 36.2%€77k▲ 14.7%€78k▲ 1.1%€66k▼ 14.4%
Operating result€22k-€25k▲ 11.2%€14k▼ 44.1%€1k▼ 91.6%€-11k
Net result€16k-€18k▲ 11.2%€10k▼ 44.8%€808▼ 91.8%€-11k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €11k after €1k in 2024, the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €82k
Fixed assets
€4k▼ 43.0%
Current assets
€77k▼ 7.7%
Equity and liabilities €82k
Equity
€66k▼ 14.4%
Debt
€15k▲ 10.1%
The debt ratio rises from 15.2% to 18.7%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€-8k▼
2024 · €3k
Cash flow
€-8k▼
2024 · €3k
Solvency
81.3%▼
2024 · 84.8%
Current ratio
5.06▼
2024 · 6.11
Quick ratio
4.60▼
2024 · 5.95
Debt / equity
0.23▲
2024 · 0.18
ROE
-16.8%▼
2024 · 1.0%
ROA
-13.6%▼
2024 · 0.9%
Interest coverage
-181.31▼
2024 · 85.60
Debt
€15k▲
2024 · €14k
Debt ≤ 1 year
€15k▲
2024 · €14k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€92k€82k▼
Fixed assets21/28€8k€4k▼
Tangible fixed assets22/27€8k€4k▼
Furniture and vehicles24€8k€4k▼
Current assets29/58€84k€77k▼
Stocks and contracts in progress3€2k€7k▲
Stocks30/36€2k€7k▲
Amounts receivable within one year40/41€11k€8k▼
Trade receivables40€4k€2k▼
Other amounts receivable41€7k€7k▼
Cash at bank and in hand54/58€70k€61k▼
Deferred charges and accrued income490/1€461€862▲
Equity and liabilities
Total equity and liabilities10/49€92k€82k▼
Equity10/15€78k€66k▼
Contributions10/11€12k€12k=
Reserves13€65k€65k=
Distributable reserves133€65k€65k=
Profit (loss) carried forward14-€-11k
Amounts payable17/49€14k€15k▲
Amounts payable within one year42/48€14k€15k▲
Trade debts44€194€571▲
Suppliers440/4€194€571▲
Taxes, remuneration and social security45-€260
Taxes450/3-€260
Other amounts payable47/48€14k€14k▲
Accrued charges and deferred income492/3€169-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k▲
Other operating charges640/8€945€1k▲
Gross operating margin9900€4k€-7k▼
Operating profit (loss)9901€1k€-11k▼
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€40€43▲
Recurring financial charges65€40€43▲
Profit (loss) for the period before taxes9903€1k€-11k▼
Income taxes67/77€311-
Profit (loss) for the period9904€808€-11k▼
Profit (loss) for the period to be appropriated9905€808€-11k▼
Appropriation of the result
Profit (loss) to be appropriated9906€808€-11k▼
Transfer to equity691/2€808-
To other reserves6921€808-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €-11k ▼1481%
Net result drops to €-11k, the lowest in the series.
26-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
18-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
01-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Liquidity triplescurrent ratio 3.02
Current ratio from 1.08 to 3.02; short-term debt falls from €89k to €15k.
12-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Highest result since 2018net €27k ▲33.6%
Net result €27k, the highest in the series.
29-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
02-05
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
08-05
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zonnebeke · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Slangenmeersstraat 98980 ZonnebekeGround area
3,504 m²
Building footprint
326 m²
Volume, LiDAR
1,781 m³
2 parcels, Flanders · tallest building 10.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
CORPUS PHARMA
since 20082.171.881.864
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33001A0163/00F000 | Flanders | 3,379 m² | 1 · 202 m² | 7.1 m · 2 fl. |
| 33037A0358/00V000 | Flanders | 125 m² | 1 · 124 m² | 10.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteZonnebeke2.171.881.864
Similar companies · same sector, comparable size
PAMEER
BE 0474.589.029
Gent · Eq €66k
Alfa Enterprise
BE 0735.357.592
Liedekerke · Eq €67k
Atelier Caffè
BE 0752.526.691
Antwerpen · Eq €66k
les Cafés La Colombe
BE 0778.935.734
Quaregnon · Eq €66k
Accompagnement Global de la Santé
BE 1004.434.901
Faimes · Eq €66k
Of 2,466 companies in sector 47279 we hold annual accounts for 942. 789 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-05-2008
Fiscal year end31-12
Activities, NACEBEL
47279Other retail sale of food
47299Retail trade
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:0477/57 81 17